Vice President, Market Access
Immunic Therapeutics
August 27, 2026
Full-time
Remote friendly (United States)
Worldwide
$340,000 - $340,000 USD yearly
Market Access
Role: Vice President of U.S. Market Access leading strategic development and organization build for vidofludimus calcium's launch in relapsing multiple sclerosis (RMS). Responsibilities: craft comprehensive payer and channel strategies, negotiate with payers, PBMs, health systems, and specialty pharmacies; develop value propositions using clinical and economic evidence; set pricing, contracting, and distribution frameworks; collaborate with Medical Affairs/HEOR on evidence and value communication; build and lead a field Market Access team across national and regional levels; coordinate with cross-functional teams on launch readiness and long-term growth. Requirements: Bachelor's degree; 15+ years in pharmaceutical/biotech leadership, with successful experience in U.S. market access, ideally for MS therapies; deep understanding of MS payer landscape, reimbursement, specialty pharmacy, and federal healthcare systems; proven success in building and leading market access organizations, especially within emerging biotech or first-launch contexts. HighValue: MS therapeutic area, specialty pharma, product launch, government and commercial payers, reimbursement strategy, field organization development. WorkSetup: not specified; likely hybrid/onsite based on senior leadership role.